(PFR)2-[Rh110] – Fluorescent Peptides

Soybean trypsin inhibitor inhibits trypsin, factor Xa, plasmin, and plasma kallikrein activity in serum-free cell culture media. It does not inhibit metallo-, cysteine, aspartic proteases, or tissue kallikrein (serine proteases). Kallikreins (KLKs) are a large family of secreted serine proteases with either trypsin-like or chymotrypsin-like specificity which carry out many biological functions. The KLK proteases are involved in pathways that regulate skin desquamation, tooth enamel formation, kidney function, seminal liquefaction, synaptic neural plasticity, and brain function. Disruptions in the function of KLK activity has been linked to several pathologies, including respiratory diseases, neurodegeneration, anxiety, schizophrenia, skin-barrier dysfunction, pathological inflammation, and cancer.

 

Technical specification

 KD20 peptide Sequence : (PFR)2-[Rho-110]
 KD20 peptide MW : 1.130.6 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
CRB1100413-0.1 mg 0.1 mg 252 € 202 $
CRB1100413-0.5 mg 0.5 mg 385 € 308 $
CRB1100413-1 mg 1 mg 533 € 427 $
CRB1100413-
CRB1100413-

For Bulk Orders